TIGC Symposium 2008
CURRENT AND UPCOMING ANTICOAGULATION OPTIONS FOR DVT, PE AND ATRIAL FIBRILATION
TORONTO PARK HYATT HOTEL, TORONTO, ON, May 23rd 2008
Learning Objectives:
- Apply the updated treatment for DVT and PE
- Understand new developments in antithrombotic therapy for
atrial fi brillation
- Discuss the rationale and process of new drug development
- Reflect upon recent data on the effi cacy of novel agents
- Thrombosis interest Group of Canada (TIGC) is dedicated to furthering
education and research in the prevention and treatment of thrombosis.”
|
